DLL1 and urinary bladder cancer: These findings are consistent with genetic evidences indicating that somatic mutations in genes coding for Notch pathway components occur in urothelial tumors41–44 and downregulation of NOTCH1 and DLL1 transcript levels in bladder cancer cells45.